Skip to Content

R 540 (Carbidopa and levodopa 25 mg / 250 mg)

Pill imprint R 540 has been identified as Carbidopa and levodopa 25 mg / 250 mg.

Carbidopa/levodopa is used in the treatment of restless legs syndrome; parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Carbidopa and levodopa 25 mg / 250 mg R 540 Front
Carbidopa and levodopa 25 mg / 250 mg R 540 Back
Carbidopa and levodopa 25 mg / 250 mg R 540
Carbidopa and levodopa
R 540
25 mg / 250 mg
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
National Drug Code (NDC):
Inactive Ingredients:
corn starch
FD&C Blue No. 2
magnesium stearate
microcrystalline cellulose
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0094 Amerisource Health Services
00904-6238 Major Pharmaceuticals
54868-2834 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.